Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin
Authors
Keywords
-
Journal
European Journal of Pharmacology
Volume -, Issue -, Pages 176137
Publisher
Elsevier BV
Online
2023-11-07
DOI
10.1016/j.ejphar.2023.176137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy
- (2023) Yiwen Cao et al. PHYTOMEDICINE
- Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
- (2022) Anastasia V. Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of farnesoid X receptor and its role in bile acid metabolism
- (2022) John Y.L. Chiang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Activating PGC-1α-mediated signaling cascades in the aorta contributes to the amelioration of vascular senescence and atherosclerosis by 2,3,4′,5-tetrahydroxystilbene-2-O-β-d-glycoside
- (2022) Chun Yan Wang et al. PHYTOMEDICINE
- Different Pathways of Cellular Cholesterol Efflux
- (2022) Alexander D. Dergunov et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice
- (2022) Anli Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport
- (2022) Liuyi Zheng et al. Frontiers in Pharmacology
- Recent Insights into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases
- (2021) Feng Jiao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis
- (2021) Michinori Matsuo JOURNAL OF PHARMACOLOGICAL SCIENCES
- Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review
- (2020) Xiao Ma et al. Frontiers in Pharmacology
- Small rodent models of atherosclerosis
- (2020) Yihan Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
- (2020) Andrea Bonnin Márquez et al. Biomedicines
- Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport
- (2019) Yi Peng et al. PHYTOMEDICINE
- Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice
- (2018) Hong-Bo Xiao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis
- (2018) Adil Rasheed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
- (2018) Xiao-Hua Yu et al. PROGRESS IN LIPID RESEARCH
- Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation
- (2017) Huan Li et al. INFLAMMATION
- Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice
- (2015) Lijing Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cholesterol efflux is LXRα isoform-dependent in human macrophages
- (2014) A Zhi Sha Ma et al. BMC Cardiovascular Disorders
- Paeoniflorin acts as a liver X receptor agonist
- (2013) Hsiang-Ru Lin JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
- (2010) Giuseppe Lo Sasso et al. Cell Metabolism
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now